Repros Therapeutics (RPRX) Misses Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Repros Therapeutics (RPRX) Misses Q2 EPS by 6c

Repros Therapeutics Inc.(R) Reports Second Quarter 2015 Financial Results

August 10, 2015 9:15 AM EDT

THE WOODLANDS, Texas, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced financial results for the second quarter ended June 30, 2015.

Financial Results

Net loss for the three month period ended June 30, 2015, was ($7.8) million or ($0.32) per share as compared to a net loss of ($8.7) million or ($0.38) per share for the same period in 2014. The net loss for the six month period ended June 30, 2015, was ($16.3) million or ($0.67) per share as compared to a net loss of ($17.5) million or ($0.76) per share for the same period in 2014. The decreases were primarily due to... More

Repros Therapeutics Inc.(R) Reports Second Quarter 2015 Financial Results

August 10, 2015 9:15 AM EDT

THE WOODLANDS, Texas, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced financial results for the second quarter ended June 30, 2015.

Financial Results

Net loss for the three month period ended June 30, 2015, was ($7.8) million or ($0.32) per share as compared to a net loss of ($8.7) million or ($0.38) per share for the same period in 2014. The net loss for the six month period ended June 30, 2015, was ($16.3) million or ($0.67) per share as compared to a net loss of ($17.5) million or ($0.76) per share for the same period in 2014. The decreases were primarily due to... More